Display options
Cite
Eteraf-Oskouei T, Allahyari S, Akbarzadeh-Atashkhosrow A, et al. Methanolic Extract of Ficus carica Linn. Leaves Exerts Antiangiogenesis Effects Based on the Rat Air Pouch Model of Inflammation. Evid Based Complement Alternat Med. 2015;2015:760405doi: 10.1155/2015/760405.
Eteraf-Oskouei, T., Allahyari, S., Akbarzadeh-Atashkhosrow, A., Delazar, A., Pashaii, M., Gan, S. H., & Najafi, M. (2015). Methanolic Extract of Ficus carica Linn. Leaves Exerts Antiangiogenesis Effects Based on the Rat Air Pouch Model of Inflammation. Evidence-based complementary and alternative medicine : eCAM, 2015760405. https://doi.org/10.1155/2015/760405
Eteraf-Oskouei, Tahereh, et al. "Methanolic Extract of Ficus carica Linn. Leaves Exerts Antiangiogenesis Effects Based on the Rat Air Pouch Model of Inflammation." Evidence-based complementary and alternative medicine : eCAM vol. 2015 (2015): 760405. doi: https://doi.org/10.1155/2015/760405
Eteraf-Oskouei T, Allahyari S, Akbarzadeh-Atashkhosrow A, Delazar A, Pashaii M, Gan SH, Najafi M. Methanolic Extract of Ficus carica Linn. Leaves Exerts Antiangiogenesis Effects Based on the Rat Air Pouch Model of Inflammation. Evid Based Complement Alternat Med. 2015;2015:760405. doi: 10.1155/2015/760405. Epub 2015 Apr 21. PMID: 25977699; PMCID: PMC4419259.
Copy Download .nbib Format: NLM
Share it on

Evid Based Complement Alternat Med. 2015;2015:760405. doi: 10.1155/2015/760405. Epub 2015 Apr 21.

Methanolic Extract of Ficus carica Linn. Leaves Exerts Antiangiogenesis Effects Based on the Rat Air Pouch Model of Inflammation.

Evidence-based complementary and alternative medicine : eCAM

Tahereh Eteraf-Oskouei, Saeideh Allahyari, Arezu Akbarzadeh-Atashkhosrow, Abbas Delazar, Mahdiyeh Pashaii, Siew Hua Gan, Moslem Najafi

Affiliations

  1. Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz 5166414766, Iran ; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 5166414766, Iran.
  2. Student Research Committee, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 5166414766, Iran.
  3. Department of Pharmacognosy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 5166414766, Iran.
  4. Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.
  5. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 5166414766, Iran.

PMID: 25977699 PMCID: PMC4419259 DOI: 10.1155/2015/760405

Abstract

The antiangiogenesis effect of Ficus carica leaves extract in an air pouch model of inflammation was investigated in rat. Inflammation was induced by injection of carrageenan into pouches. After antioxidant capacity and total phenolic content (TPC) investigations, the extract was administered at 5, 25, and 50 mg/pouch, and then the volume of exudates, the cell number, TNFα, PGE2, and VEGF levels were measured. Angiogenesis of granulation tissues was determined by measuring hemoglobin content. Based on the DPPH assay, the extract had significant antioxidant activity with TPC of 11.70 mg GAE/100 g dry sample. In addition, leukocyte accumulation and volume of exudate were significantly inhibited by the extract. Moreover, it significantly decreased the production of TNFα, PGE2, and VEGF, while angiogenesis was significantly inhibited by all administered doses. Interestingly, attenuation of angiogenesis and inflammatory parameters (except leukocyte accumulation) by the extract was similar to that shown by diclofenac. The extract has anti-inflammatory effects and ameliorated cell influx and exudation to the site of the inflammatory response which may be related to the local inhibition of TNFα, PGE2, and VEGF levels as similarly shown by diclofenac. The antiangiogenesis and anti-VEGF effects of Ficus carica may be correlated with its significant antioxidant potentials.

References

  1. Curr Med Chem. 2000 Nov;7(11):1163-70 - PubMed
  2. Yakugaku Zasshi. 2003 May;123(5):295-303 - PubMed
  3. Curr Protoc Pharmacol. 2012 Mar;Chapter 5:Unit5.6 - PubMed
  4. Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):3-8 - PubMed
  5. Korean J Physiol Pharmacol. 2009 Dec;13(6):417-24 - PubMed
  6. J Immunol. 1988 Oct 1;141(7):2388-93 - PubMed
  7. J Exp Med. 2002 Apr 15;195(8):973-82 - PubMed
  8. Blood. 2011 Nov 10;118(19):5355-64 - PubMed
  9. Int Immunopharmacol. 2012 Aug;13(4):476-82 - PubMed
  10. Arthritis Res. 2002;4 Suppl 3:S81-90 - PubMed
  11. J Pathol. 1996 Sep;180(1):90-4 - PubMed
  12. J Ethnopharmacol. 2008 Sep 26;119(2):195-213 - PubMed
  13. Joint Bone Spine. 2003 Sep;70(5):321-6 - PubMed
  14. J Integr Med. 2014 Jul;12(4):336-45 - PubMed
  15. Evid Based Complement Alternat Med. 2012;2012:150458 - PubMed
  16. J Pharmacol Toxicol Methods. 1994 Nov;32(3):139-47 - PubMed
  17. Mod Rheumatol. 2002 Jun;12(2):93-9 - PubMed
  18. Keio J Med. 2012;61(2):47-56 - PubMed
  19. Eur J Pharm Sci. 2005 May;25(1):25-30 - PubMed
  20. Pharmacoeconomics. 2004;22(2 Suppl 1):1-12 - PubMed
  21. J Pathol. 1983 Dec;141(4):483-95 - PubMed
  22. Proc Soc Exp Biol Med. 1983 Feb;172(2):214-8 - PubMed
  23. Medicine (Baltimore). 1984 May;63(3):165-81 - PubMed
  24. Arthritis Rheum. 2004 Jan;50(1):72-7 - PubMed
  25. Cytokine Growth Factor Rev. 2007 Jun-Aug;18(3-4):335-43 - PubMed
  26. Eur Cytokine Netw. 2006 Sep;17(3):202-10 - PubMed
  27. J Pharmacol Exp Ther. 2000 Nov;295(2):802-9 - PubMed
  28. Nat Med. 2003 Jun;9(6):653-60 - PubMed
  29. Acta Haematol. 2001;106(4):148-56 - PubMed
  30. Pharmacol Rev. 2001 Mar;53(1):135-59 - PubMed
  31. Ann Rheum Dis. 1992 Jul;51(7):919-25 - PubMed
  32. J Pathol. 1981 Jun;134(2):147-56 - PubMed
  33. Exp Mol Med. 2005 Dec 31;37(6):588-600 - PubMed

Publication Types